Additional European Equity News

Anglo American (AAL LN) - Q3 Production Update: Copper 184kt (prev. 181kt Y/Y), Iron Ore 14.3Mt (prev. 15.7Mt). CEO said “are well positioned to meet 2025 guidance, with the full year outlook increased at our Minas-Rio iron ore operation in Brazil”. (Anglo American)

Airtel Africa (AAF LN) - H1 (USD): Revenue 2.98bln (prev. 2.37bln Y/Y), Op. Profit 959mln (prev. 706mln Y/Y). Capex guidance for FY'26 has been increased to between 875-900mln. (Airtel Africa)    

Air Liquide (AI FP) - Q3 (EUR): Revenue 6.6bln (exp. 6.65bln). Affirms guidance. (Newswires) 

AstraZeneca (AZN LN) - Co.’s selumetinib drug, Koselugo, has been approved in the EU. (AstraZeneca)  

Balder (BALDB SS) - 9M (SEK): Net income 5.581bln, rental income 10.269bln. (Balder)   

Barclays (BARC LN) - Co. to buy Best EGG for USD 80mln. (Barclays) 

Delivery Hero (DHER GY) - Co. has sold its entire stake in Tabby as it achieves a solid return on its initial investment. (Newswires)

Evoke (EVOK LN) - Q3 (GBP): Revenue 435mln, +5% Y/Y. Reiterated 2025 guidance. UK&I Online: 1% revenue growth, with growth in sports (+8%) helped by weaker prior year win margins, offset by gaming (-2%). (Evoke)     

GSK (GSK LN) - Co. to enter a licence agreement with Empirico for clinical-stage oligonucleotide candidate to treat respiratory diseases, to pay USD 85mln upfront and up to USD 660mln in milestone payments; in other news, the Co.’s B7-H3 targeted antibody-drug conjugate has received Orphan Drug Designation in the EU. (GSK)

Iberdrola (IBE SM) - Q3 (EUR): Revenue 11.12bln (exp. 11.55bln), net income 1.74bln (exp. 1.37bn), raises FY25 adj. net outlook to 'double-digit growth'. (Iberdrola)

28 Oct 2025 - 07:07- MetalsEU Research- Source: Newsquawk